IntriCon Corporation (IIN) Stock
IIN is no longer traded. IntriCon was delisted from the Nasdaq in May 2022.
Prices on this page are historical; the last trade was May 24, 2022 at $24.24.
IntriCon stock price history
IIN final trading statistics
- Final close
- $24.24
- Final trading day
- May 24, 2022
- Market cap at delisting
- $225.49M
- Shares outstanding
- 9.30M
- Final 52-week range
- $12.47 – $25.15
- Avg. volume (final 3 mo.)
- 154,455
- All-time high (split-adj.)
- $76.60 · Sep 2018
- All-time low (split-adj.)
- $0.70 · Dec 1982
- Return since IPO
- +1384.7%
- Beta
- 1.01
- Book value / share
- $10.07
- Price / book
- 2.41
IntriCon annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $125.21M | -$106.0K | $0.47 |
| FY2020 | $102.77M | -$2.5M | -$0.05 |
| FY2019 | $113.49M | -$3.8M | $0.16 |
| FY2018 | $116.46M | $5.5M | $0.66 |
| FY2017 | $88.31M | $1.8M | $0.32 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About IntriCon Corporation
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.
IntriCon stock FAQ
What happened to IntriCon stock?
IntriCon stock was delisted from the Nasdaq. Its final close was $24.24 on May 24, 2022.
Is IIN stock still trading?
No. IIN was delisted from the Nasdaq in May 2022 and no longer trades on a U.S. exchange.
What was the last price of IIN stock?
IIN closed at $24.24 on its final trading day, May 24, 2022, for a market value of about $225.49M.
What were IntriCon's revenue and earnings in its last full fiscal year?
IntriCon reported revenue of $125.21M and net income of -$106.0K in fiscal 2021, its last full year as a public company.
When did IntriCon go public?
IntriCon Corporation stock began trading on March 17, 1980.